Application 021488

Type
NDA
Sponsor
TOLMAR THERAP

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ELIGARDLEUPROLIDE ACETATEINJECTABLE;SUBCUTANEOUS30MG/VIALYesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021488-001ELIGARD KITLEUPROLIDE ACETATE30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-13

Orange Book patents#

Current patent rows page 1 of 1 · 3 matching rows.

Application-product, Patent, Expiration table
Application-productPatentExpirationUse codeCoverage / statusSubmission date
N021488-001117718412041-12-22Drug substance, Drug product2023-10-27
N021488-001119315592041-12-22Drug substance2024-04-15
N021488-001123971202041-12-22U-40012025-09-22

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-13011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-1331067a03dcf5…
2025-08-23 18:47 UTC2025-08N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-136a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-13fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-13b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-1303ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-132680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-135bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-13d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-13d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-1379d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-13301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-131e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-138072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-135c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-135d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-134b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N021488-001ELIGARD30MG/VIALINJECTABLE / SUBCUTANEOUSRLD, RS2003-02-1374a2ff9319b5…
2022-03-09 01:35 UTC2022-03N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-13bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-13782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-1387673890dc5c…
2021-03-12 10:30 UTC2021-03N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-135aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-138869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-13c0c555d07b60…
2019-12-14 00:12 UTC2019-12N021488-001ELIGARD30MG/VIALINJECTABLE / SUBCUTANEOUSRLD, RS2003-02-133f01610625f2…
2019-09-15 20:21 UTC2019-09N021488-001ELIGARD30MG/VIALINJECTABLE / SUBCUTANEOUSRLD, RS2003-02-13b00525d2431f…
2019-07-19 19:46 UTC2019-07N021488-001ELIGARD30MG/VIALINJECTABLE / SUBCUTANEOUSRLD, RS2003-02-13ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-136a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-131c564ffb4f44…
2023-12-20 04:57 UTC2023-12N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-13ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-13a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-139b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-13a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-133f0d92c62455…
2023-05-13 08:27 UTC2023-05N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-13053a50430f4f…
2023-01-26 05:58 UTC2023-01N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-133bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-133a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-13f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-13e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N021488-001ELIGARD KIT30MGPOWDER / SUBCUTANEOUSRLD, RS2003-02-13cb3db0bc1861…

Observed Orange Book patent history#

Patent history page 1 of 2 · 79 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2026-02-19 14:30 UTC2026-02N021488-001117718412041-12-22Drug substance, Drug product2023-10-27011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021488-001119315592041-12-22Drug substance2024-04-15011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021488-001123971202041-12-22U-40012025-09-22011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021488-001117718412041-12-22Drug substance, Drug product2023-10-2731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021488-001119315592041-12-22Drug substance2024-04-1531067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021488-001123971202041-12-22U-40012025-09-2231067a03dcf5…
2025-08-23 18:47 UTC2025-08N021488-001117718412041-12-22Drug substance, Drug product2023-10-276a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021488-001119315592041-12-22Drug substance2024-04-156a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021488-001117718412041-12-22Drug substance, Drug product2023-10-27fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021488-001119315592041-12-22Drug substance2024-04-15fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021488-001117718412041-12-22Drug substance, Drug product2023-10-27b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021488-001119315592041-12-22Drug substance2024-04-15b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021488-001117718412041-12-22Drug substance, Drug product2023-10-2703ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021488-001119315592041-12-22Drug substance2024-04-1503ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021488-001117718412041-12-22Drug substance, Drug product2023-10-272680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021488-001119315592041-12-22Drug substance2024-04-152680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021488-001117718412041-12-22Drug substance, Drug product2023-10-275bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021488-001119315592041-12-22Drug substance2024-04-155bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021488-001117718412041-12-22Drug substance, Drug product2023-10-27d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021488-001119315592041-12-22Drug substance2024-04-15d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021488-001117718412041-12-22Drug substance, Drug product2023-10-27d06236e962d9…
2024-10-29 15:01 UTC2024-10N021488-001119315592041-12-22Drug substance2024-04-15d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021488-001117718412041-12-22Drug substance, Drug product2023-10-2779d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021488-001119315592041-12-22Drug substance2024-04-1579d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021488-001117718412041-12-22Drug substance, Drug product2023-10-27301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021488-001119315592041-12-22Drug substance2024-04-15301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021488-001117718412041-12-22Drug substance, Drug product2023-10-271e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021488-001119315592041-12-22Drug substance2024-04-151e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021488-001117718412041-12-22Drug substance, Drug product2023-10-278072bd15b7f6…
2024-05-31 18:47 UTC2024-05N021488-001119315592041-12-22Drug substance2024-04-158072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021488-00184703592023-10-15U-621Drug substance, Drug product2017-01-315c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N021488-00184703592023-10-15U-621Drug substance, Drug product2017-01-315d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N021488-00184703592023-10-15U-621Drug substance, Drug product2017-01-314b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N021488-00166268702020-03-27Drug product74a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021488-00188409162020-11-13Drug product2017-01-3174a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021488-00195393332020-11-13U-621Drug substance, Drug product2017-01-3074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021488-00184703592023-10-15U-621Drug substance, Drug product2017-01-3174a2ff9319b5…
2022-03-09 01:35 UTC2022-03N021488-00184703592023-10-15U-621Drug substance, Drug product2017-01-31bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N021488-00184703592023-10-15U-621Drug substance, Drug product2017-01-31782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N021488-00184703592023-10-15U-621Drug substance, Drug product2017-01-3187673890dc5c…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VabrintyLEUPROLIDE ACETATEURONOVA PHARMACEUTICALS, INC.008776cc-83f1-4f8c-819b-6471425da15f2026-04-30Warnings, Adverse reactionsExact identifier
application applno (NDA): 021488
application number: NDA021488
EligardLEUPROLIDE ACETATETOLMAR Inc.b7b679a9-6823-4ef8-8d31-3ab5058ffcfc2026-04-30Warnings, Adverse reactionsExact identifier
application applno (NDA): 021488
application number: NDA021488
ELIGARDLEUPROLIDE ACETATETOLMAR Inc.b78d1919-9dee-44fa-90f9-e0a26d32481d2019-04-29Warnings, Adverse reactionsExact identifier
application applno (NDA): 021488
application number: NDA021488
ndc (product): 62935-303

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 13 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
62935-302ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-303ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-303ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-303ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-303ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-303ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-303ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-303ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-303ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-303ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-303ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-303ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-303ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85889SUPPL 2026-05-12
85854SUPPL 2026-05-08
81371SUPPL 2025-02-25
81346SUPPL 2025-02-25
81015SUPPL 2025-02-06
80965SUPPL 2025-02-06
78531SUPPL 2024-05-22
78530SUPPL 2024-05-22
77295SUPPL 2024-01-25
77287SUPPL 2024-01-24
74862SUPPL 2023-07-21
74861SUPPL 2023-07-21
74852SUPPL 2023-07-21
74851SUPPL 2023-07-21
57735SUPPL2019-02-21
57698SUPPL2019-02-19
37058SUPPL2016-03-03
5526SUPPL2016-03-02
37057SUPPL2014-10-15
5525SUPPL2014-10-14
27921SUPPL2013-03-01
15589SUPPL2013-03-01
23667ORIG2011-12-20
27920SUPPL2011-04-11
15588SUPPL2011-04-11
27919SUPPL2011-01-20
15587SUPPL2011-01-20
27918SUPPL2010-10-13
15586SUPPL2010-10-12
5524SUPPL2007-11-19
37056SUPPL2007-11-13
27917ORIG2004-06-03
5523SUPPL2004-01-14
21688ORIG2003-05-08
37055ORIG2003-02-13